Funded Tech Companies

EpimAb Biotherapeutics

Based in Shanghai, EpimAb Biotherapeutics has funding from Oriza Ventures, 3E Bioventures and private investors.

Company Overview

Company Name
EpimAb Biotherapeutics
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
6th Floor Building 2 Jinchuang Building 702 Zhongke Rd. Zhan 205
Shanghai, 201204
China
Email Address
Not Recorded

Company Background Information

Overview
EpimAb Biotherapeutics is a privately owned biopharmaceutical company dedicated to generating novel bi-specific antibody therapeutics based on its proprietary FIT-Ig (Fabs-In-Tandem) platform.
Profile
EpimAb Biotherapeutics LinkedIn Company Profile
Social Media
EpimAb Biotherapeutics Company Twitter Account
Company News
EpimAb Biotherapeutics News
Facebook
EpimAb Biotherapeutics on Facebook
YouTube
EpimAb Biotherapeutics on YouTube
Last Transaction
4/26/2017

Financing History

Date
Type
Amount
Venture Equity
$25,000,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Chengbin Wu
  Chengbin Wu LinkedIn Profile  Chengbin Wu Twitter Account  Chengbin Wu News  Chengbin Wu on Facebook
Chief Marketing Officer
Bin Peng
  Bin Peng LinkedIn Profile  Bin Peng Twitter Account  Bin Peng News  Bin Peng on Facebook
Chief Operating Officer
Stephan Lensky
  Stephan Lensky LinkedIn Profile  Stephan Lensky Twitter Account  Stephan Lensky News  Stephan Lensky on Facebook
Vice President
Jerry Su
  Jerry Su LinkedIn Profile  Jerry Su Twitter Account  Jerry Su News  Jerry Su on Facebook
VP - Regulatory Affairs
Richard Jiang
  Richard Jiang LinkedIn Profile  Richard Jiang Twitter Account  Richard Jiang News  Richard Jiang on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Epilot | Epinote

 

Share this article

 


About Our Venture Capital Database

The company data above is provided by VentureDeal.com, a market leader in private equity transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary